C
China Pharma Holdings Inc (CPHI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX
$0.70
-0.02 (-2.85%)
Market Cap: $32.33M
Last updated: Oct 16, 2026 at 1:55 PM ET
Earnings
Key Metrics
Technical Indicators Dashboard
Moving Averages
SMA 10$0.77
SMA 20$0.73
SMA 50$0.85
SMA 200$0.86
EMA 10$0.76
EMA 20$0.76
EMA 50$0.84
EMA 200$0.98
MACD
Line: -0.02Signal: -0.03Hist: 0.01
ADX
ADX: 59.1+DI: 33.8-DI: 10.8
Aroon & PSAR
Aroon Up76.0
Aroon Down52.0
PSAR$1.27
Bollinger Bands
Upper Band$0.91
Lower Band$0.55
%B Position4892%(Upper)
Band Width0.41
RSI (14-Day)
Neutral
44.4
Momentum Oscillators
Stoch %K17.0
Stoch %D25.1
Williams %R-86.6
ROC (10d)7.1%
Momentum0.05
CCI (20d)-31.0
MFI (14d)95.1
Volatility Measures
ATR (14d)$0.15(21.8%)
StdDev (20d)0.09
Hist Vol151.0%(High)
Volume Flow
VWAP$0.70
OBV232.7M
AD Line-36.3M
CMF (20d)-0.269
Volume Metrics
Avg Vol (20d)4.8M
Vol Ratio0.1x(Low)
VWMA (20d)$0.87
Pivot Points
R3$0.79
R2$0.76
R1$0.74
Pivot Point$0.70
S1$0.69
S2$0.65
S3$0.63
Advanced Oscillators
TSI-5.13
Ultimate Osc41.0
KST-69.27
Financial Data
Related GNG Research
No research available
Be the first to write about CPHI
News
CPHI Valuation and Fair Value
- Forward P/E
- 1.6x
- PEG
- 0.2x
- P/B
- 0.8x
CPHI Profitability: Margins, ROIC and FCF
- Gross margin
- 11.8%
- Operating margin
- -151.0%
- Net margin
- -114.3%
- ROIC
- -8.7%
- ROE
- -21.0%
- FCF margin
- -4.5%
CPHI Competitors
Sector: Healthcare
CPHI Bull Case vs Bear Case
Bear case
- CPHI has a -114.3% net profit margin.
- CPHI beat EPS estimates in 0.0% of its last 8 reported quarters.
- CPHI's quarterly revenue changed -7.5% year over year.
CPHI Earnings: Beat Rate and Next Report
- Beat rate
- 0 of 8 quarters (0.0%)
Frequently Asked Questions About CPHI
Does CPHI pay dividends?
China Pharma Holdings Inc (CPHI) does not currently pay a regular dividend.
What is CPHI's market cap?
China Pharma Holdings Inc (CPHI) has a market capitalization of $32.33M with a current stock price of $0.70.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.